The National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021, has been passed in Lok Sabha.
As per the NIPER Amendment Bill 2021, a total of six additional National Institutes of Pharmaceutical Education and Research (NIPERs) will now be considered as institutions of national importance.
In order to spread and strengthen the pharmaceutical education and research in India, the NIPER (Amendment) Bill, 2021 has been passed in Lok Sabha. All the parties in the Lok Sabha house supported the NIPERs (Amendment) Bill, 2021.
As the Lok Sabha has passed the bill, six National Institutes of Pharmaceutical Education and Research Institutions in Kolkata, Guwahati, Hyderabad, Ahmedabad, Raebareli, and Hajipur will get the status of national importance.
An institution of national importance means that an autonomous institute has the authority to hold examinations, grant degrees, diplomas and other academic distinctions or titles and receive funding from the Central Government.
Earlier in 2009-08, these six institutes were established, who contributed significantly during the Covid-19 circumstances across the country.
NIPER (Amendment ) Bill, 2021, was introduced in the Lok Sabha on March 15, 2021, to amend the National Institute of Pharmaceutical Education and Research Act, 1998, which had set up the NIPER at Mohali and it was amended via the current bill.
As the bill received the approval in Lok Sabha, Dr Mansukh Mandaviya, Union Minister of Health and Family Welfare, expressed his happiness and tweeted that he was delighted to witness Lok Sabha passing the NIPER (Amendment) bill 2021, after a long debate and that the bill received much support.
Minister Dr @MansukhMandviya ji speaking on the National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021, in the Lok Sabhahttps://t.co/RuFuelGiyC
— Office of Dr Mansukh Mandaviya (@OfficeOf_MM) December 6, 2021
Further, he said in the Parliament that earlier, the NIPERs were offering only masters and PhD degree courses, but the amendment suggested including undergraduate courses as well.
There are over 10,000 pharmaceutical industries in India. While the big industries have research systems, small industries lack such systems. Therefore, small industries can adopt NIPER's help for research, which will eventually be cost-effective for industries and the NIPER students will also get hands-on research training experience, Mandaviya said.
Also Read:
